Eton Pharmaceuticals Ownership | Who Owns Eton Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Eton Pharmaceuticals Ownership Summary


Eton Pharmaceuticals is owned by 72.83% institutional investors, 5.17% insiders, and 21.99% retail investors. Opaleye management is the largest institutional shareholder, holding 10.48% of ETON shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.54% of its assets in Eton Pharmaceuticals shares.

ETON Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEton Pharmaceuticals72.83%5.17%21.99%
SectorHealthcare Stocks 50.50%12.33%37.17%
IndustrySpecialty & Generic Drug Manufacturers Stocks34.33%15.05%50.62%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Opaleye management2.86M10.48%$103.53M
Ecor1 capital2.17M7.96%$78.62M
Blackrock funding, inc. /de1.90M6.95%$68.63M
Vanguard group1.35M5.01%$22.81M
Nantahala capital management1.18M4.31%$42.57M
Vanguard capital management976.57K3.58%$35.35M
Morgan stanley767.97K2.81%$27.80M
State street701.79K2.57%$25.40M
Geode capital management652.30K2.39%$23.62M
Oberweis asset management inc/501.60K1.84%$18.16M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Opaleye management2.86M9.38%$103.53M
Cannell capital341.99K5.18%$8.44M
Ecor1 capital2.17M3.82%$78.62M
Panoramic capital208.19K3.24%$7.54M
Prospect capital advisors157.20K2.58%$5.69M
Westside investment management431.16K2.05%$15.61M
Lumbard & kellner175.91K1.93%$6.37M
Nantahala capital management1.18M1.42%$42.57M
Aristides capital145.41K1.02%$5.26M
Bridge city capital88.13K0.73%$3.19M

Top Buyers

HolderShares% AssetsChange
Nuveen375.71K0.00%317.76K
Morgan stanley767.97K0.00%290.01K
D. e. shaw188.45K0.00%188.45K
Blackrock funding, inc. /de1.90M0.00%178.55K
State street701.79K0.00%171.57K

Top Sellers

HolderShares% AssetsChange
Parkman healthcare partners---276.89K
Paradigm capital management inc/ny---200.00K
Divisadero street capital management, lp298.00K0.28%-199.72K
Acuitas investments---185.82K
Soleus capital management---166.38K

New Positions

HolderShares% AssetsChangeValue
Norges bank169.50K0.00%169.50K$6.14M
Prospect capital advisors157.20K2.58%157.20K$5.69M
Wasatch advisors lp92.74K0.02%92.74K$3.36M
Sixth street partners management company77.03K0.00%77.03K$2.79M
Dimensional fund advisors lp42.48K0.00%42.48K$1.54M

Sold Out

HolderChange
Lindbrook capital-4.00
Twin peaks wealth advisors-38.00
Advisory services network-50.00
Daiwa securities group-89.00
Vermillion & white wealth management group-150.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202617040.50%19,872,62811.74%721.71%11681.25%32-3.03%
Mar 31, 202652-50.00%3,591,014-77.40%130.38%27-43.75%15-59.46%
Dec 31, 202562-40.38%8,912,362-49.64%330.77%30-45.45%22-18.52%
Sep 30, 20259818.07%17,454,5999.66%641.85%51-12.07%2758.82%
Jun 30, 202586-1.15%16,537,10735.73%612.99%6115.09%17-26.09%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF681.72K2.54%-
Vanguard Total Stock Mkt Idx Inv684.82K2.50%30.10K
Vanguard Morn Total Stk Mkt Idx Investor684.82K2.50%30.10K
iShares Russell 2000 ETF678.89K2.48%-12.10K
Oberweis Micro-Cap Growth483.90K1.77%63.00K
Oberweis Micro-Cap420.90K1.54%-
Vanguard Institutional Extnd Mkt Idx Tr271.00K0.99%9.49K
Fidelity Small Cap Index254.53K0.93%1.17K
Nuveen Quant Small Cap Equity R6253.38K0.90%-5.02K
iShares Russell 2000 Growth ETF240.47K0.88%-2.21K

Recent Insider Transactions


DateNameRoleActivityValue
Jul 14, 2026Opaleye Management Inc.-Sell$499.89K
Jul 14, 2026Opaleye Management Inc.-Sell$563.15K
Jul 02, 2026Opaleye Management Inc.-Sell$2.43M
Jul 06, 2026Opaleye Management Inc.-Sell$380.00K
Jul 07, 2026Opaleye Management Inc.-Sell$767.46K

Insider Transactions Trends


DateBuySell
2026 Q3-7
2026 Q2-8
2026 Q1--
2025 Q4--
2025 Q3-2

ETON Ownership FAQ


Who Owns Eton Pharmaceuticals?

Eton Pharmaceuticals shareholders are primarily institutional investors at 72.83%, followed by 5.17% insiders and 22.00% retail investors. The average institutional ownership in Eton Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.33%, which Eton Pharmaceuticals exceeds.

Who owns the most shares of Eton Pharmaceuticals?

Eton Pharmaceuticals’s largest shareholders are Opaleye management (2.86M shares, 10.48%), Ecor1 capital (2.17M shares, 7.96%), and Blackrock funding, inc. /de (1.9M shares, 6.95%). Together, they hold 25.39% of Eton Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eton Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Eton Pharmaceuticals.

Who is Eton Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Opaleye management is Eton Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 9.38% of its assets in 2.86M Eton Pharmaceuticals shares, valued at 103.53M$.

Who is the top mutual fund holder of Eton Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Eton Pharmaceuticals shares, with 2.54% of its total shares outstanding invested in 681.72K Eton Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools